US 8933110
Hepatitis C virus inhibitors
granted A61KA61K31/415A61K31/4188
Quick answer
US patent 8933110 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/415, A61K31/4188, A61K31/4196, A61K31/424